» Articles » PMID: 913969

Cancer in Colitis: Assessment of the Individual Risk by Clinical and Histological Criteria

Overview
Specialty Gastroenterology
Date 1977 Dec 1
PMID 913969
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The cancer risk among 229 patients with extensive ulcerative colitis observed during January 1, 1966 to February 29, 1976 is correlated with the length of history and the histological findings in rectal and colonic biopsies. Five patients are known to have developed carcinoma. No carcinoma was observed in 578 patient years of follow-up within 10 years of onset of the colitis, but the risk in the second decade was approximately 1 in 200 patient years and in the third, 1 in 60 patient years. Severe epithelial dysplasia was rare and found in 32 biopsies from 13 patients. No carcinoma has occurred during the period of follow-up in patients without dysplasia. It has not been possible to follow the development of dysplasia in sequential biopsies. Seven patients with consistent severe dysplasia on biopsy have been treated surgically; carcinoma confined to the bowel wall (Dukes' A) was found in 4. A scheme of management for patients with extensive colitis, including regular rectal and colonic biopsies, is proposed. Our results suggest that such a program will isolate a small group of patients who require surgical treatment for established precancerous change or carcinoma with a high likelihood of cure.

Citing Articles

Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists.

Wu X, Liu H, Shi X, Zhou W, Jiang Z, Huang Y Gastroenterol Res Pract. 2018; 2018:8715263.

PMID: 29849600 PMC: 5937390. DOI: 10.1155/2018/8715263.


Colorectal dysplasia and adenocarcinoma in patients with ulcerative colitis: an experience from a tertiary care hospital.

Younus N, Abid M, Hashmi A, Aijaz S, Edhi M, Sheikh A World J Surg Oncol. 2018; 16(1):81.

PMID: 29673364 PMC: 5909273. DOI: 10.1186/s12957-018-1385-7.


Cyclooxygenase-2 gene polymorphisms and the risk of colorectal cancer: A population-based study.

Li H, Guo Q, Zhou B, He S Oncol Lett. 2015; 10(3):1863-1869.

PMID: 26622766 PMC: 4533694. DOI: 10.3892/ol.2015.3477.


Ulcerative colitis: the fate of the retained rectum.

Juviler A, Hyman N Clin Colon Rectal Surg. 2009; 17(1):29-34.

PMID: 20011282 PMC: 2780074. DOI: 10.1055/s-2004-823068.


Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer.

Cox D, Pontes C, Guino E, Navarro M, Osorio A, Canzian F Br J Cancer. 2004; 91(2):339-43.

PMID: 15173859 PMC: 2409800. DOI: 10.1038/sj.bjc.6601906.